← Back to Search

Alpha-1 Agonist

Midodrine for Low Blood Pressure (SCI Trial)

Phase 4
Recruiting
Research Sponsored by James J. Peters Veterans Affairs Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial

Summary

This trial aims to understand how different treatments for low blood pressure, both non-drug and drug-based, affect the body's responses to changing positions, symptoms of autonomic dysreflexia and orth

Who is the study for?
This trial is for individuals with a spinal cord injury (SCI) that happened at least a year ago, affecting the C1-T6 regions of the spine. Participants must be non-ambulatory and have an AIS grade A, B, or C, indicating varying levels of impairment.
What is being tested?
The study is testing Midodrine Hydrochloride to see how it affects blood pressure regulation in people with SCI who experience low blood pressure when they stand up (orthostatic hypotension).
What are the potential side effects?
Midodrine may cause side effects like tingling scalp sensations, goosebumps, nausea, digestive issues or urinary problems. It can also potentially increase blood pressure too much.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Systolic blood pressure
Secondary study objectives
Cerebral blood flow velocity
Symptoms of autonomic dysreflexia and orthostatic hypotension

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Study 2Experimental Treatment1 Intervention
Determine the effects of compression garments, midodrine, and droxidopa, compared to placebo, on orthostatic hemodynamics, symptoms of AD and OH and reporting of fatigue and thermal comfort.
Group II: Study 1Experimental Treatment1 Intervention
Twenty-five participants will be asked to visit the laboratory on 6 occasions, for an open-label, dose escalation trial to determine the effect of midodrine and droxidopa on supine and seated blood pressure and on symptoms of autonomic dysreflexia and orthostatic hypotension.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Midodrine Hydrochloride
2007
Completed Phase 3
~150

Find a Location

Who is running the clinical trial?

James J. Peters Veterans Affairs Medical CenterLead Sponsor
57 Previous Clinical Trials
2,855 Total Patients Enrolled
9 Trials studying Hypotension
533 Patients Enrolled for Hypotension
Kessler FoundationOTHER
181 Previous Clinical Trials
11,054 Total Patients Enrolled
4 Trials studying Hypotension
71 Patients Enrolled for Hypotension
~14 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top